Recombinant Protein Therapeutics Market Report

Global and Region Recombinant Protein Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：150
  • REPORT CODE：GMM948783
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Recombinant Protein Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Protein Therapeuticsmarket, defines the market attractiveness level of Recombinant Protein Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Recombinant Protein Therapeutics industry, describes the types of Recombinant Protein Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Protein Therapeutics market and the development prospects and opportunities of Recombinant Protein Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Protein Therapeutics market in Chapter 13.

    By Player:

    • Merck

    • Roche

    • Biogen

    • Ligand

    • Sanofi

    • Pfizer

    • Amgen

    • J&J

    • Eli Lilly

    • Bayer

    By Type:

    • Recombinant Hormones

    • Interferons

    • Interleukins

    • Hematopoietic Growth Factors

    • Others

    By End-User:

    • Diabetes

    • Dwarfism

    • Heart Disease

    • Cancer

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Recombinant Protein Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Recombinant Protein Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Recombinant Protein Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Recombinant Protein Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Recombinant Protein Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Recombinant Protein Therapeutics Consumption (2017-2022)

    • 7.2 United States Recombinant Protein Therapeutics Consumption (2017-2022)

    • 7.3 Europe Recombinant Protein Therapeutics Consumption (2017-2022)

    • 7.4 China Recombinant Protein Therapeutics Consumption (2017-2022)

    • 7.5 Japan Recombinant Protein Therapeutics Consumption (2017-2022)

    • 7.6 India Recombinant Protein Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Recombinant Protein Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Recombinant Protein Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Recombinant Protein Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Recombinant Protein Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Recombinant Protein Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Recombinant Protein Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Recombinant Protein Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Recombinant Protein Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Recombinant Protein Therapeutics Consumption Forecast (2022-2028)

    9 Global Recombinant Protein Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Recombinant Protein Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Recombinant Hormones Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Interferons Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Interleukins Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Hematopoietic Growth Factors Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Recombinant Protein Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Dwarfism Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Heart Disease Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Recombinant Protein Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Recombinant Protein Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Recombinant Hormones Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Interferons Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Interleukins Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Hematopoietic Growth Factors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Recombinant Protein Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Dwarfism Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Heart Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Recombinant Protein Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Recombinant Protein Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Recombinant Protein Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Recombinant Protein Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Recombinant Protein Therapeutics Market Competitive Analysis

    • 14.1 Merck

      • 14.1.1 Merck Company Details

      • 14.1.2 Merck Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Merck Recombinant Protein Therapeutics Product and Service

    • 14.2 Roche

      • 14.2.1 Roche Company Details

      • 14.2.2 Roche Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Roche Recombinant Protein Therapeutics Product and Service

    • 14.3 Biogen

      • 14.3.1 Biogen Company Details

      • 14.3.2 Biogen Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Biogen Recombinant Protein Therapeutics Product and Service

    • 14.4 Ligand

      • 14.4.1 Ligand Company Details

      • 14.4.2 Ligand Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Ligand Recombinant Protein Therapeutics Product and Service

    • 14.5 Sanofi

      • 14.5.1 Sanofi Company Details

      • 14.5.2 Sanofi Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanofi Recombinant Protein Therapeutics Product and Service

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Details

      • 14.6.2 Pfizer Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Recombinant Protein Therapeutics Product and Service

    • 14.7 Amgen

      • 14.7.1 Amgen Company Details

      • 14.7.2 Amgen Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Amgen Recombinant Protein Therapeutics Product and Service

    • 14.8 J&J

      • 14.8.1 J&J Company Details

      • 14.8.2 J&J Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 J&J Recombinant Protein Therapeutics Product and Service

    • 14.9 Eli Lilly

      • 14.9.1 Eli Lilly Company Details

      • 14.9.2 Eli Lilly Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Eli Lilly Recombinant Protein Therapeutics Product and Service

    • 14.10 Bayer

      • 14.10.1 Bayer Company Details

      • 14.10.2 Bayer Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bayer Recombinant Protein Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Recombinant Protein Therapeutics

    • Figure Recombinant Protein Therapeutics Picture

    • Table Global Recombinant Protein Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Protein Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Protein Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Recombinant Protein Therapeutics Consumption by Country (2017-2022)

    • Figure United States Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Protein Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Hormones Consumption and Growth Rate (2017-2022)

    • Figure Global Interferons Consumption and Growth Rate (2017-2022)

    • Figure Global Interleukins Consumption and Growth Rate (2017-2022)

    • Figure Global Hematopoietic Growth Factors Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Dwarfism Consumption and Growth Rate (2017-2022)

    • Figure Global Heart Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Hormones Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Interferons Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Interleukins Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hematopoietic Growth Factors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dwarfism Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Recombinant Protein Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Recombinant Protein Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Recombinant Protein Therapeutics Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Recombinant Protein Therapeutics Product and Service

    • Table Biogen (Foundation Year, Company Profile and etc.)

    • Table Biogen Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Recombinant Protein Therapeutics Product and Service

    • Table Ligand (Foundation Year, Company Profile and etc.)

    • Table Ligand Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ligand Recombinant Protein Therapeutics Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Recombinant Protein Therapeutics Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Recombinant Protein Therapeutics Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Recombinant Protein Therapeutics Product and Service

    • Table J&J (Foundation Year, Company Profile and etc.)

    • Table J&J Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table J&J Recombinant Protein Therapeutics Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Recombinant Protein Therapeutics Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Recombinant Protein Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US